drugset / Trial / NCT00933348

Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers

NCT00933348 ↗

Phase 2 Suspended 30 enrolled Phoenix Eagle Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine the safety and efficacy of the fruit-based product OPAL A for the treatment of chronic venous and pressure ulcers.

Timeline

Start
2010-01
Primary completion
2016-12
Completion
2016-12

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment caused rethink on the study design”

Drugs

EvaluationDrugModalityDoseRoute
Comparator OPAL A Unknown 0.5 ml Topical
Comparator OPAL A Unknown 1 g Topical
Comparator OPAL A Unknown 5 g Topical